Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Dermatology Practical & Conceptual|April 26, 2014
Primary adenomyoepithelioma of the skin - a variant of apocrine mixed tumor?Elisabeth Riedl, Geoffrey J GottliebThe Journal of Investigative Dermatology|June 12, 2004
Identification and characterization of an alternatively spliced isoform of mouse Langerin/CD207Elisabeth Riedl, Yayoi Tada, Mark C UdeyDermatology Practical & Conceptual|September 26, 2022
Application of an Interactive Diagnosis Ranking Algorithm in a Simulated Vignette-based Environment for General DermatologyAntonia Wesinger, Elisabeth Riedl, Harald Kittler, et al.Journal of the American Academy of Dermatology|January 19, 2010
Dermatoscopy of pigmented Bowen's diseaseAlan Cameron, Cliff Rosendahl, Philipp Tschandl, et al.Pharmacoeconomics|March 5, 2020
Modeling Heterogeneity in Patients' Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class ApproachesMarco Boeri, Daniel Saure, Alexander Schacht, et al.Journal of Drugs in Dermatology : JDD|June 8, 2022
Subgroup Analyses by European Country-Specific Reimbursement Requirements Confirm Efficacy for Ixekizumab in PsoriasisElisabeth Riedl, Ulrich Mrowietz, Julie Hill B, et al.Pediatric Dermatology|March 3, 2009
A novel glycine mutation in the COL7A1 gene leading to dominant dystrophic epidermolysis bullosa with intra-familial phenotypical heterogeneityElisabeth Riedl, Alfred Klausegger, Johann W Bauer, et al.Dermatology Practical & Conceptual|June 21, 2013
A study assessing the feasibility and diagnostic accuracy of real-time teledermatopathologyElisabeth Riedl, Masoud Asgari, Diana Alvarez, et al.The Journal of Dermatological Treatment|April 22, 2020
A subset analysis of efficacy and safety outcomes from phase 3 clinical studies of ixekizumab for the treatment of patients with severe plaque psoriasisLynda Spelman, Diana Rubel, Alan Brnabic, et al.Acta Dermato-Venereologica|October 20, 2017
Patients' Illness Perception as a Tool to Improve Individual Disease Management in Primary Cutaneous LymphomasStefanie Porkert, Eva Lehner-Baumgartner, Julia Valencak, et al.Pageof 4